{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:10:47Z","timestamp":1791159047847,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.patbio.2003.09.018","type":"journal-article","created":{"date-parts":[[2004,1,27]],"date-time":"2004-01-27T10:23:12Z","timestamp":1075198992000},"page":"343-350","source":"Crossref","is-referenced-by-count":10,"title":["La maladie de Gaucher\u00a0: aspects cliniques, g\u00e9n\u00e9tiques et th\u00e9rapeutiques"],"prefix":"10.1016","volume":"52","author":[{"given":"D.P","family":"Germain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2003.09.018_BIB1","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.patbio.2003.09.018_BIB2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/1040-8428(96)00199-0","article-title":"Gaucher disease: a prototype for molecular medicine","volume":"23","author":"Grabowski","year":"1996","journal-title":"Critical Rev Oncol Hematol"},{"key":"10.1016\/j.patbio.2003.09.018_BIB3","first-page":"659","article-title":"Gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Bailliere's Clinic Haematology"},{"key":"10.1016\/j.patbio.2003.09.018_BIB4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<28::AID-AJH5>3.0.CO;2-5","article-title":"Abdominal ultrasound findings mimicking hematological malignancies in a study of 218\u00a0Gaucher patients","volume":"55","author":"Neudorfer","year":"1997","journal-title":"Am J Haematol"},{"key":"10.1016\/j.patbio.2003.09.018_BIB5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.patbio.2003.09.018_BIB6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","article-title":"Pulmonary hypertension in type 1\u00a0Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy","volume":"77","author":"Mistry","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.patbio.2003.09.018_BIB7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1034\/j.1399-0004.2003.00060.x","article-title":"Pulmonary involvement in type 1\u00a0Gaucher disease: functional and exercise findings in patients with and without clinical interstitial lung disease","volume":"63","author":"Miller","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.patbio.2003.09.018_BIB8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.1996.03530310054033","article-title":"Gaucher disease. Current issues in diagnosis and treatment","volume":"275","author":"NIH Technology Assessment Panel on Gaucher Disease","year":"1996","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.patbio.2003.09.018_BIB9","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archinte.158.16.1754","article-title":"Gaucher disease: recommendations on diagnosis, evaluation, and monitoring","volume":"158","author":"Charrow","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.patbio.2003.09.018_BIB10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028\u00a0patients with type 1\u00a0Gaucher disease after two to five years of treatment: a report from the Gaucher registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.patbio.2003.09.018_BIB11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/archneur.1993.00540110088009","article-title":"The role of neurogenetics in Gaucher disease","volume":"50","author":"Brady","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.patbio.2003.09.018_BIB12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1010514614570","article-title":"Neuronopathic Gaucher Disease Task Force of the European Working Group on Gaucher Disease. Neuronopathic Gaucher disease task force of the European working group on Gaucher disease. Management of neuronopathic Gaucher disease a European consensus","volume":"24","author":"Vellodi","year":"2001","journal-title":"J Inher Metab Dis"},{"key":"10.1016\/j.patbio.2003.09.018_BIB13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1986.tb14936.x","article-title":"Gaucher disease: Norrbottnian type 3. Neuropediatric and neurobiological aspects of clinical patterns and treatment","volume":"326","author":"Erikson","year":"1986","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.patbio.2003.09.018_BIB14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(95)91688-1","article-title":"A new Gaucher disease variant characterized by progressive calcification of heart valves and an unique genotype","volume":"346","author":"Abrahamov","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2003.09.018_BIB15","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.82.21.7289","article-title":"Molecular cloning and nucleotide sequence of the human glucocerebrosidase gene","volume":"82","author":"Sorge","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.patbio.2003.09.018_BIB16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0888-7543(89)90319-4","article-title":"The human glucocerebrosidase gene and pseudogene: structure and evolution","volume":"4","author":"Horowitz","year":"1989","journal-title":"Genomics"},{"key":"10.1016\/j.patbio.2003.09.018_BIB17","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.patbio.2003.09.018_BIB18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2003.09.018_BIB19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6","article-title":"Glucocerebrosidase (Gaucher disease)","volume":"8","author":"Beutler","year":"1996","journal-title":"Hum Mutat"},{"key":"10.1016\/j.patbio.2003.09.018_BIB20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/301969","article-title":"Exhaustive screening of the acid beta-glucosidase gene, by fluorescence- assisted mismatch analysis using universal primers: mutation profile and genotype\u2013phenotype correlations in Gaucher disease","volume":"63","author":"Germain","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"21","key":"10.1016\/j.patbio.2003.09.018_BIB21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency \u2013\u2013 macrophage targeted glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2003.09.018_BIB22","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199305273282112","article-title":"Treatment of Gaucher's disease","volume":"328","author":"Barton","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2003.09.018_BIB23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1\u00a0Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"1","author":"Grabowski","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.patbio.2003.09.018_BIB24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0929-693X(03)00286-0","article-title":"Gaucher\u2019s disease in children: first clinical signs, natural course and benefits of enzyme replacement therapy","volume":"8","author":"Caubel","year":"2003","journal-title":"Arch. Pediatr"},{"key":"10.1016\/j.patbio.2003.09.018_BIB25","first-page":"503","article-title":"Epidemiologic, clinical, biological and therapeutic aspects of Gaucher disease","volume":"11","author":"Stirnemann","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.patbio.2003.09.018_BIB26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1051\/jbio\/2002196020141","article-title":"Gaucher's disease","volume":"196","author":"Belmatoug","year":"2002","journal-title":"J Soc Biol"},{"key":"10.1016\/j.patbio.2003.09.018_BIB27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/qjmed\/91.7.483","article-title":"Low-dose low-frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type I Gaucher disease","volume":"91","author":"Elstein","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.patbio.2003.09.018_BIB28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/bcmd.2000.0310","article-title":"Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease","volume":"26","author":"Altarescu","year":"2000","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.patbio.2003.09.018_BIB29","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1182\/blood.V93.6.2081.406k07_2081_2088","article-title":"Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration","volume":"93","author":"Rosenberg","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2003.09.018_BIB30","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1542\/peds.100.6.e11","article-title":"Management of neutralizing antibody to Ceredase in a patient with type 3\u00a0Gaucher Disease","volume":"100","author":"Brady","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.patbio.2003.09.018_BIB31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0027-5107(01)00232-9","article-title":"Mutation analysis of the acid beta-glucosidase gene in a patient with type 3\u00a0Gaucher disease and neutralizing antibody to alglucerase","volume":"483","author":"Germain","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/j.patbio.2003.09.018_BIB32","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2003.09.018_BIB33","doi-asserted-by":"crossref","DOI":"10.1006\/bcmd.2002.0497","article-title":"Low-dose N\u2013butyldeoxynojirimycin (OGT 918) for type I Gaucher disease","volume":"28","author":"Heitner","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.patbio.2003.09.018_BIB34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/13543784.12.2.273","article-title":"Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1","volume":"12","author":"Pastores","year":"2003","journal-title":"Expert Opinion Investig Drugs"},{"key":"10.1016\/j.patbio.2003.09.018_BIB35","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperons increase the cellular activity of N370S beta-glucosidase: a therapeutic option for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.patbio.2003.09.018_BIB36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.1998.tb01053.x","article-title":"Comparison of methods for retroviral mediated transfer of glucocerebrosidase gene to CD34+ hematopoietic progenitor cells","volume":"61","author":"Takiyama","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.patbio.2003.09.018_BIB37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/mthe.2002.0650","article-title":"Demonstration of feasibility of in vivo gene therapy for Gaucher disease using a chemically induced mouse model","volume":"6","author":"Marshall","year":"2002","journal-title":"Mol Ther"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811403002931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811403002931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T10:42:20Z","timestamp":1585478540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811403002931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0369811403002931"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2003.09.018","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}